For analyses by drug type, semaglutide and liraglutide were evaluated separately, while dulaglutide, exenatide, and unspecified glucagon-like peptide-1 agonists were grouped as other GLP-1RAs. Furthermore, the study's primary financial endpoints comprised two measures
Clinical data supports the idea that staying on a stable dose preserves weight loss benefits indefinitely
Hrd1 and ER-associated protein degradation, ERAD, are critical elements of the adaptive ER stress response in cardiac myocytes
As doses increase, more side effects are likely to occur, but is weight gain one of them
Regarding safety, the most common adverse events among people treated with Ozempic (semaglutide injection) for its indicated use, are gastrointestinal events including nausea, diarrhoea and vomiting